Mounjaro market prices in the UK right now: what you're really paying for

You've found a headline price, here's what it may not include

Picture this: you've spent twenty minutes on a comparison site, spotted a figure that looks manageable, and you're about to click through. Then the consultation fee loads. Then the prescription charge. Then delivery. By the checkout page, the number looks different. This is a pattern the full picture on Mounjaro pricing describes in more detail, but the short version is that the UK private market for tirzepatide is not as transparent as it could be.

Headline prices for Mounjaro are most commonly quoted per pen, for a single dose tier, without wrapping in the costs that surround it. Consultation fees range from zero to over £50 depending on the provider. Prescription fees may be charged separately. Delivery is sometimes free, sometimes not. Follow-up clinical support (the kind you need when you increase a dose and feel rough for a week) may cost extra or simply not exist. Add those up across a course of treatment and the cheapest-looking pen can become the most expensive month.

A factual note on the current market: Mounjaro prices across UK private providers typically sit between roughly £149 and £375 per month, varying by dose and what's bundled in. Those figures are widely reported following Lilly's September 2025 list-price change. If you're specifically comparing at the higher end of the dose range, our tirzepatide 30mg price page sets out what that tier realistically costs and what to look for in a quoted figure. Treat any quote significantly below that range with caution, and any quote significantly above it as worth interrogating for what's included.

What the current Mounjaro market looks like by dose tier

The dose you're on is probably the biggest single driver of what you pay each month. Mounjaro is prescribed across six strength tiers in the UK (2.5mg through to 15mg) and treatment begins at the lowest level regardless of where you end up long-term. If you're wondering what the starter tier costs relative to maintenance doses, the 2.5mg price page and the 5mg price page both carry up-to-date market context for those levels specifically.

One practical detail that sometimes catches people out: if you order on a Monday before 12pm and your prescriber approves you that day, your pen ships same day and arrives Tuesday. Timing your order around payday or a long weekend is worth thinking through, a bank holiday can push delivery by a day, and missing a weekly dose because the pen arrived late is frustrating when it's avoidable.

The per-pen pricing breakdown is a useful reference if you want to understand what different dose levels cost in isolation. But a pen price on its own is not a treatment cost. For a realistic monthly figure you need to know whether your consultation, your prescription, any dose-review appointments, and your delivery are wrapped in or charged on top. Market-level price comparisons pull those elements together in one place.

Where nume sits in this market, and why we've chosen that position

We're not the cheapest option. That's a deliberate choice, not an oversight. Our pricing reflects a service built around clinical rigour: a real prescriber reads your consultation the same day, ID and weight are verified before treatment is approved, your GP is notified in line with GPhC guidance, and your pen travels in tracked DPD packaging to arrive the next working day. None of that is optional infrastructure, it's what makes treatment safe and effective.

The single price you see on our treatment page includes your consultation, your prescription, your medicine, and your delivery. There's no membership fee, no separate prescription surcharge, no aftercare paywall. Our clinical team is available seven days a week and responds to questions that actually matter: what to do if you're vomiting after a dose increase, whether a new medication interacts, when to pause treatment. That's included too.

The NICE appraisal of tirzepatide (TA1026) and the NHS tirzepatide medicines page both set out clearly that this is a prescription medicine requiring proper clinical oversight. A price that strips that oversight out to shave off a few pounds is not a good deal, it's a different product. The cost context page for Mounjaro expands on this if you want to read further before deciding.

Why 'cheapest' is the wrong question for a prescription medicine

There's a useful MHRA warning that's easy to skip past: fake tirzepatide pens have entered the UK market, some containing insulin instead of the labelled medicine, seized in quantities running to tens of millions of doses worth around £45 million at street value. The prices at which those products were being offered were, by definition, low. A discount that looks surprising on a prescription medicine should prompt a question, not a purchase.

Any legitimate supplier of Mounjaro can be verified on the GPhC register. You can check a pharmacy's registration directly at the GPhC premises register, and we'd encourage you to. Our registration number is 9012878. If a seller can't point you to a GPhC-registered pharmacy operating from a licensed UK supply chain, that gap in the answer is its own answer.

For a treatment you'll be using weekly over months, clinical continuity matters as much as cost. A prescriber who reviewed you at the start but can't be reached when a side effect worries you at week eight is not the same service as one with seven-day aftercare built in. Price is an input to a decision, not the decision itself. If you're ready to see what treatment looks like through a properly supervised route, speak to our prescribers via a free consultation.